PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 5.36
-0.09 (-1.65%)
Jul 31, 2026, 4:08 PM HKT
PegBio Market Cap
PegBio has a market cap or net worth of 2.1 billion as of July 31, 2026. Its market cap has decreased by -63.60% in one year.
Market Cap
2.10B
Enterprise Value
1.62B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.36
ChartMarket Cap Chart
Since May 27, 2025, PegBio's market cap has decreased from 4.46B to 2.10B, a decrease of -53.02%. That is a compound annual growth rate of -47.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.10B | -92.23% |
| Dec 31, 2025 | 26.99B | 504.83% |
| May 27, 2025 | 4.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 2.78B |
| Viva Biotech Holdings | 2.70B |
| Antengene Corporation | 2.63B |
| TYK Medicines | 2.62B |
| Clover Biopharmaceuticals | 2.60B |
| Laekna | 2.56B |
| BioDlink International Company | 2.48B |
| Frontage Holdings | 2.37B |